An Artificial Intelligence-Powered Platform for Prostate Cancer Grading

While the Gleason grading system has been the most reliable tool for the prognosis of prostate cancer since its development, its clinical application remains limited. A study examined the impact of an artificial intelligence (AI)-assisted approach to prostate cancer grading and quantification. The findings were published in JAMA Network Open. This diagnostic study was conducted from August 2, 2017, to December 30, 2019. The study consisted of 589 men (mean age, 63.8 years) with biopsy-confirmed prostate cancer who received care in the University of Wisconsin Health System between January 1, 2005, and February 28, 2017.